Clinical trial
Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock Patients
NCT03308227 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock Patients
- Lead sponsor
- Southeast University, China
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 20, 2017
- Completion date
- April 30, 2018
- Enrollment
- 46 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock